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The purpose of this study is to compare 7- and 30-day readmission rates, 
emergency department (ED) revisit rates, and length of stay for two cohorts of 
patients: (1) patients that had a medication history performed by a pharmacist 
and (2) patients that received usual care. The findings from this study will 
be used to further determine the role of a pharmacist conducting medication 
histories at Lehigh Valley Hospital (LVH). 
•  Preventable readmissions following recent discharge may result from actions 
taken or omitted during a hospital stay. 
•  An area where action can be taken to prevent readmissions is decreasing the 
amount of medication discrepancies between a patient’s home medication 
regimen and the prescribed inpatient medication regimen.
•  At LVH, prescribers (MD, DO, CRNP, PA), nurses (RN), or medication 
reconciliation pharmacy technicians (MRT) perform a medication history when 
a patient is admitted to the hospital.
  −  Initial review of medication histories shows a high percentage of errors 
when medication histories are performed by prescribers and RNs. 
•  When compared to nurses or physicians, pharmacists are able to obtain 
a more accurate medication history from patients with less medication 
discrepancies that potentially can lead to harmful medication errors. 
  −  Pharmacist involvement may lead to fewer discrepancies, a decrease in 
30-day readmissions, less revisits to the ED and a shorter length of stay.
•  This study will evaluate the impact of a pharmacist performing inpatient 
medication histories and compare length of stay, 7- and 30-day readmission 
rates and ED revisit rates between time periods when a pharmacist completed 
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•  Retrospective chart review of two patient cohorts: (1) patients who had a 
medication history performed by a pharmacist and (2) patients who had a 
medication reconciliation performed via usual care. 
•  INCLUSION CRITERIA  
  −  Patients discharged from a single medical/surgical unit 
    •  Cohort 1 – Patients discharged between September 1, 2017 and 
September 30, 2017
    •  Cohort 2 – Patients discharged between September 1, 2016 and 
September 30, 2016
•  EXCLUSION CRITERIA  
  −  Medication reconciliation was performed by a MRT
  −  Patient discharged to skilled nursing facility or hospice care 
  −  Patient admitted in previous 30 days from start of study period for each 
cohort
  −  Patient transferred to another hospital 
  −  Patient died before discharge
•  The primary objectives are to compare 30-day readmission rates and ED revisit 
rates during a time in which a pharmacist conducted a medication history 
compared to a time of usual care.
•  Secondary objectives
  −  Compare the length of stay and 7-day readmission rates for patients 
during a time in which a pharmacist conducted a medication history 
compared to a time of usual care. 
•  Electronic medical records for patients discharged from a single medical/surgical 
unit during the specified time periods will be reviewed. 
•  Data to be collected for patients in each cohort will include:
  −  Patient’s age, gender, admission date, discharge date, length of stay, ED visit 
date and readmission risk score (if applicable). 
•  Statistical analyses
  −  Chi-Square Test of Independence will be performed to determine whether an 
association exists between readmission and ED revisit rates and the provider 
obtaining the medication history. If the result is statistically significant, 
pairwise comparisons will be performed to see which specific groups are 
different from each other. 
  −  ANOVA will be utilized to evaluate whether length of stay differs between 
cohorts. If the result is statistically significant, pairwise comparisons will be 
done to see which specific groups are different from each other. 
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